Verona Pharma plc
A biopharmaceutical company developing and commercializing a dry powder inhalation of ensifentrine, an inhibitor of phosphodiesterase 3 and 4, for respiratory diseases. The company is developing treatments for cystic fibrosis, asthma, chronic obstructive pulmonary disease, and other conditions.
Overview
Overview | |
|---|---|
Country | United Kingdom |
State | |
Employees | 79 |
Founded | 2005 |
Financials | |
|---|---|
Market Capitalization | 1.77B |
Revenue | |
Operating Income | -72.57M |
Operating Margin | |
Net Income | -63.42M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4639 / 5373 |
Sector : Healthcare | 806 / 1144 |
Industry : Biotechnology | 386 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2047 / 5565 |
Sector : Healthcare | 256 / 1182 |
Industry : Biotechnology | 92 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4490 / 5436 |
Sector : Healthcare | 779 / 1164 |
Industry : Biotechnology | 376 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4181 / 5330 |
Sector : Healthcare | 689 / 1174 |
Industry : Biotechnology | 288 / 667 |